Skip to main content

Metformin Effective in Osteoarthritis

The diabetes drug metformin provided overweight/obese patients with osteoarthritis (OA) of the knee with significantly greater pain relief than did placebo in a small randomized trial, researchers said.

Simplistic overview of Lupus Nephritis - causes, risk factors, symptoms, diagnosis, and treatment of lupus nephritis. ht

Social Author Name
Dr. John Cush
Tweet Content
Simplistic overview of Lupus Nephritis - causes, risk factors, symptoms, diagnosis, and treatment of lupus nephritis. https://t.co/QkLXUQcSqo https://t.co/pGjCHmoelG

Unmet Needs in Still’s disease In February 2023, an expert consensus panel of pediatric and adult rheumatologists me

Social Author Name
Dr. John Cush
Tweet Content
Unmet Needs in Still’s disease In February 2023, an expert consensus panel of pediatric and adult rheumatologists met to address challenges in Still’s disease (SD), including systemic juvenile idiopathic arthritis (sJIA) and adult-onset SD (AOSD). They addressed four main https://t.co/h6FNkQyoKj

2025 BSR Guideline for Treatment of Axial Spondyloarthritis The British Society of Rheumatology has published its 2025

Social Author Name
Dr. John Cush
Tweet Content
2025 BSR Guideline for Treatment of Axial Spondyloarthritis The British Society of Rheumatology has published its 2025 Guidelines for the Treatment of Axial Spondyloarthritis (axSpA); addressing axial and extra-musculoskeletal manifestations including acute anterior uveitis, https://t.co/IRdxsZTFdC

Better Responses with Chronotherapy for Baricitinib A nonrandomized, open-label, controlled trial has shown superior e

Social Author Name
Dr. John Cush
Tweet Content
Better Responses with Chronotherapy for Baricitinib A nonrandomized, open-label, controlled trial has shown superior efficacy when baricitinib was given at night (instead of day); attesting to the benefits of chronotherapy - selective dosing meant to target the body's diurnal https://t.co/jSrPdoOpmo

Post-treatment Lyme Syndrome Symptoms that persist long after Lyme disease is treated are not uncommon — a 2022 stud

Social Author Name
Dr. John Cush
Tweet Content
Post-treatment Lyme Syndrome Symptoms that persist long after Lyme disease is treated are not uncommon — a 2022 study found that 14% of patients who were diagnosed and treated early with antibiotic therapy would still develop Post Treatment Lyme Disease (PTLD). https://t.co/mmwGCnARY8

Senescent "Zombie" Cells and Low Back Pain In a preclinical study led by McGill University researchers, two drugs targ

Social Author Name
Dr. John Cush
Tweet Content
Senescent "Zombie" Cells and Low Back Pain In a preclinical study led by McGill University researchers, two drugs targeting “zombie cells” have been shown to treat the underlying cause of chronic low back pain. The condition affects millions of people worldwide. https://t.co/UxHH3bMGkQ

Diabetes Prevention with Hydroxychloroquine in Sjogren’s A Taiwanese insurance claims analysis looked at HCQ use in

Social Author Name
Dr. John Cush
Tweet Content
Diabetes Prevention with Hydroxychloroquine in Sjogren’s A Taiwanese insurance claims analysis looked at HCQ use in primary Sjögren syndrome (pSS) and showed that HCQ exposure significantly reduces the risk of new onset diabetes in pSS. Conversely, higher doses of https://t.co/GS07GVp5pC

🦋 This May, RheumNow brings you Lupus Unlocked – Keys to Mastery Your one-stop hub for lupus education: ✅ Expert

Social Author Name
Dr. John Cush
Tweet Content
🦋 This May, RheumNow brings you Lupus Unlocked – Keys to Mastery Your one-stop hub for lupus education: ✅ Expert KOL content ✅ Weekly webinars & podcasts ✅ Engaging surveys + slides Sponsored by Aurinia — empowering HCPs to advance care. #Lupus #Rheumatology https://t.co/rf4GveV3eh
Subscribe to
×